Showing results (151-160 of 166) with videos related to
Sort By:
Pageof 17
Annals of Clinical Biochemistry|May 23, 2023
Dataset dependency of low-density lipoprotein-cholesterol estimation by machine learningIshida Hidekazu, Hiroki Nagasawa, Yasuko Yamamoto, et al.Plos Pathogens|May 12, 2021
Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigenIan Baudi, Masanori Isogawa, Federica Moalli, et al.Echocardiography (Mount Kisco, N.Y.)|October 19, 2023
Resting echocardiographic parameters can exclude significant coronary artery disease: A comparison with coronary computed tomography angiographyShinji Jinno, Akira Yamada, Kunihiko Sugimoto, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 18, 2010
Acid sphingomyelinase regulates glucose and lipid metabolism in hepatocytes through AKT activation and AMP-activated protein kinase suppressionYosuke Osawa, Ekihiro Seki, Yuzo Kodama, et al.Leukemia & Lymphoma|April 25, 2015
High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemiaRyoko Mabuchi, Takeshi Hara, Takuro Matsumoto, et al.International Journal of Hematology|August 6, 2015
Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model miceNobuhiko Nakamura, Takeshi Hara, Masahito Shimizu, et al.Annals of Hematology|October 13, 2010
Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOPSoranobu Ninomiya, Takeshi Hara, Hisashi Tsurumi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 21, 2026
Suppression of Indoleamine 2,3-Dioxygenase Enhances Immune Responses to the Therapeutic Vaccine for Chronic Hepatitis BYohei Shirakami, Soranobu Ninomiya, Takayasu Ideta, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.Vaccines|July 27, 2024
Humoral and Cellular Response Induced by Primary Series and Booster Doses of mRNA Coronavirus Disease 2019 Vaccine in Patients with Cardiovascular Disease: A Longitudinal StudyYuya Ishihara, Hiroyuki Naruse, Hidetsugu Fujigaki, et al.Pageof 17